Delcath Systems, Inc. (DCTH) Earnings Call Analysis

NASDAQ · Healthcare · Medical Devices

21/25

Growth 5 Margin 4 Expansion 3 Platform 5 Financial 4

latest quarter score

Earnings Reports

21
Delcath Systems (DCTH) Q2 2026: Hepsado Kit Volume Jumps 30% as Center Expansion Targets Top Cancer Hubs
August 07, 2026
13
DCTH Q1 2026: 36% Volume Growth Signals Expanding PHP Adoption, but Europe Lags on Reimbursement
May 07, 2026
18
Delcath Systems (DCTH) Q4 2025: R&D Spend to Rise 90% as Site Activations and Chopin Data Set Stage for 2026 Expansion
February 27, 2026
11
DelCast Systems (DCTH) Q3 2025: Chopin Data Drives 150% Hepsado Volume Surge Despite Patient Start Dip
October 22, 2025
15
DCTH Q2 2025: Hepsado Volume Soars 175% as Site Expansion Slows, Margin Pressures Emerge
August 06, 2025
16
DCTH Q1 2025: Gross Margin Jumps to 86% as Center Expansion Accelerates U.S. Adoption
July 06, 2025
Delcath Systems (DCTH) Q4 2024: Hepsado Launch Drives $32.3M Revenue and Positive Adjusted EBITDA
March 06, 2025

Browse all companies